Controlled clinical trial to assess the response of recent heroin abusers with chronic hepatitis C virus infection to treatment with interferon alpha-n2b
Authors:
- Sergio NeriSNSergio Neri
- Cosimo M. BrunoCBCosimo M. Bruno
- Giuseppe AbateGAGiuseppe Abate
- Dario IernaDIDario Ierna
- Barbara MauceriBMBarbara Mauceri
- Danila CilioDCDanila Cilio
- Fabio BordanaroFBFabio Bordanaro
- Davide PulvirentiDPDavide Pulvirenti
- Claudio ItalianoCIClaudio Italiano
- Luciano CarusoLCLuciano Caruso
- 31 October 2002
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 24 (10) , 1627-1635
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Treatment of Hepatitis C Infection in Injection Drug UsersHepatology, 2001
- Cytokines and Cell Surface Receptors as Target End Points of Immunosuppression with Cyclosporine AJournal of Interferon & Cytokine Research, 2001
- Epidemiology of hepatitis CHepatology, 1997
- Hepatitis C: The clinical spectrum of diseaseHepatology, 1997
- Peripancreatic lymphoadenopathy and extrahepatic immunological manifestations in chronic hepatitis CEuropean Journal of Clinical Investigation, 1996
- Positive and negative immunomodulation by opioid peptidesInternational Journal of Immunopharmacology, 1996
- Prediction of response to interferon treatment of chronic hepatitis CJournal of Hepatology, 1994
- Neuroendocrine Peptide Receptors on Cells of the Immune System1992
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†Hepatology, 1981
- Immunologic dysfunction in heroin addictsArchives of internal medicine (1960), 1974